Verlinvest, a global, consumer-focused, evergreen investment company, agreed to acquire a minority stake in Cible Skin, a French luxury skincare brand. Financial terms were not disclosed. “From the start of this partnership, we have been aligned with Raphael and Cécile on the fundamental role that science, research, and product development plays at Cible Skin. Their support will allow us to achieve our ambition of establishing Cible Skin as a global leader in scientific innovation to better serve the health and beauty of all skin types through best-in-class product efficacy,” Dr. Raphaël Aknin, Cible Skin CEO and co-founder.